Investment Banking Executive with over 30 years of experience focused on global capital markets. He is the former Managing Director and Head of Distribution and Corporate access (Asia) for Citi, where ...

The Prescription Drug User Fee Act date refers to the deadline set by the FDA for reviewing a NDA or Biologics License Application.

Trace Neuroscience aims to advance an RNA-binding therapy designed to preserve — and potentially improve — muscle function in ...

Trace Neuroscience Launches with $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases, ...

Achieved first-ever RNA editing in humans in RestorAATion-2 trial of WVE-006 (GalNAc-AIMer) in alpha-1 antitrypsin deficiency and announced three wholly owned GalNAc-AIMer preclinical programs that ...

Investors are responding to Tesla CEO Elon Musk's close association with President-elect Donald Trump, anticipating a ...

Bayer has become the latest in a long line of drug developers to give up on Huntington’s disease after the German pharma ...

Lead program in amyotrophic lateral sclerosis (ALS) is an antisense oligonucleotide that restores UNC13A protein to preserve and potentially improve muscle function UNC13A is a genetically validated ...

Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.

EBR Systems is among ASX healthcare stocks with upcoming catalysts, expecting feedback on a FDA substantive review expected ...

This innovative approach, in partnership with the Cancer Science Institute of Singapore (CSI Singapore), A*STAR, National ...

Researchers have used microcellular "drones" to deliver antisense oligonucleotide therapeutics to lung cancer cells.